Skip to main content
Equibles

BCT · BriaCell Therapeutics Corp. · Documents

Use BCT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BCT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
5.5700 CAD +0.9600 (+20.82%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Annual report FY2026 Net loss $34.9M 10-K filed Oct 28, 2026 Quarterly report FY2026 Q3 Net loss $7.16M 10-Q filed Jun 9, 2026 Latest results Financial results 8-K filed Oct 28, 2022
2026
Oct 28
Annual report 10-K FY2026, ended Jul 31
Annual report for FY2026

BriaCell advanced Bria-IMT pivotal Phase 3 enrollment past 230 patients toward planned interim analysis, reporting a net loss of $35,325,292 for year ended July 31, 2026; working capital was $14,063,292 and it intends to raise additional capital.

Net loss $34.9M Diluted EPS -$6.97
Read from the MD&A section
Oct 28
Report SEDAR+
MD&A
Jun 9
Report SEDAR+
MD&A
Mar 10
Report SEDAR+
MD&A
Showing 1–50 of 852 documents